Freenome (FRNM)
Blood-based cancer screening built on multiomic, AI-driven detection.
$16.57
vs last close−0.03 (−0.16%)
Something off on this page? Send us feedback.
Next report
Dec 2, 26
estimated · in 71 days
EPS estimate
$0.15
Revenue estimate
$84.9M
Fiscal quarter
Q4 FY26
EPSReportedEstimate
——————Jul '26Dec '26
Reported——————−$1.96Pending
Estimate——————−$1.78$0.15
Surprise——————−10.1%—
RevenueReportedEstimate
——————Jul '26Dec '26
Reported——————$2.7MPending
Estimate——————$3.0M$84.9M
Surprise——————−9.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | $0.15 | — | — |
| Jul 2026 | −$1.78 | −$1.96 | −10.1% |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2, 2026 | $0.15 | — | — | $84.9M | — | — | — |
| Jul 15, 2026 | −$1.78 | −$1.96 | −10.1% | $3.0M | $2.7M | −9.3% | +1.1% |